Brief: Adocia Initiates BC LisPram Phase 1 Clinical Trial In Pump For People With Type 1 Diabetes
June 29 (Reuters) - ADOCIA SA ADOC.PA :
* ADOCIA INITIATES BC LISPRAM PHASE 1 CLINICAL TRIAL IN PUMP
FOR
PEOPLE WITH TYPE 1 DIABETES
* FOR FIRST TIME, A UNIQUE COMBINATION OF TWO KEY HORMONES
INVOLVED IN GLYCEMIC CONTROL, A RAPID ACTING INSULIN ANALOG AND
AN AMYLIN ANALOG, IS TESTED IN A SINGLE PUMP
Source text for Eikon: ID:nBw9sKnpHa
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Adocia SA
See all newsFrench biopharma firm Adocia H1 revenue drops on weaker feasibility study income
Brief: Adocia H1 Operating Income EUR -7.947 Million
Brief: Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired
Brief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides